Revised SPC: Cellcept (mycophenolate mofetil) products

SPCs now warn that as mycophenolic acid has a cytostatic effect on B- and T-lymphocytes, an increased severity of COVID-19 may occur, thus dose reduction or discontinuation should be considered for patients in cases of clinically significant COVID-19.

Source:

electronic Medicines compendium